期刊文献+

静脉注射6%羟乙基淀粉130/0.4和呋噻米治疗急性胰腺炎 被引量:1

Role of 6% Hydroxyethylstarch 130/0.4 and Furosemide in the Treatment of Acute Pancreatitis
原文传递
导出
摘要 为观察静脉输注6%羟乙基淀粉130/0.4和静脉推注呋噻米(速尿)对急性胰腺炎病例转归的影响,选择从2007年10月16日~2009年8月31日收治的患者,入院当日即给予羟乙基淀粉静脉输注(成人通常为1 000~2 000 ml),在输注羟乙基淀粉的同时静脉推注呋噻米,力求作到出入量基本平衡;入院次日开始逐渐减少羟乙基淀粉用量。治疗135例急性胰腺炎患者(Ranson评分≥3分者54%,Balthazar CT评分≥D者61%),胰腺局部并发症和全身并发症仅为4%和7%,胰腺手术率为4%,住院死亡率为4%。通过比较入院时和痊愈后的血细胞压积,估计入院时血容量减少平均约18.3%。结果表明:静脉输注羟乙基淀粉和静脉推注呋噻米可改善急性胰腺炎的转归。血浆外渗是急性胰腺炎的中心事件和治疗重点。 This study was conducted to observe the effects of intravenously administered 6% hydroxyethylstarch 130/0.4 solution and furosemide on the outcome of acute pancreatitis patients.Patients admitted to our center from October 16,2007 through August 31,2009 were given intravenous infusions of 6% hydroxyethylstarch 130/0.4 solution(1 000-2 000 ml administered for an adult) soon after admission.At the same time,furosemide was administered as intravenous bolus,trying to maintain a fluid balance.The dose level of hydroxyethylstarch was gradually lowered from the second day after admission.A total of 135 patients(54% of patients with a Ranson's score≥3 and 61% with a Balthazar CT score≥D) were treated with our protocol.Only 4% and 7% patients developed pancreatic and systemic complications respectively;only 1 patient underwent necrosectomy.The in-hospital mortality rate was 4%.It was estimated that,on the average,18.3% of blood volume was lost on admission.Our study suggest that intravenously administered 6% hydroxyethylstarch 130/0.4 solution and furosemide might be beneficial for patients with acute pancreatitis.Plasma extravasation is a central event of acute pancreatitis.The reversal of hypovolemia is crucial for the success in treatment of acute pancreatitis.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2010年第5期1138-1141,1145,共5页 Journal of Biomedical Engineering
关键词 急性胰腺炎 羟乙基淀粉 呋噻米 Acute pancreatitis; Hydroxyethylstarch solution; Furosemide;
  • 相关文献

参考文献10

  • 1FAGENHOLZ P J, FERNANDEZ-DEL CASTILLO C, HARRIS N S, et al. Direct medical costs of acute pancreatitis hospitalization in the United States[J]. Pancreas, 2007, 35 (4): 302-307. 被引量:1
  • 2SPANIER B W, DUKGRAAF M G, BRUNO M J. Epidemiology, actiology and outcome of acute and chronic pancreatitis: An update[J]. Best Pratt Res Clin Gastroenterol, 2008, 22(1): 45-63. 被引量:1
  • 3陈灏珠主编.实用内科学,急性胰腺炎[M].北京:人民卫生出版社.2005:1963-1969. 被引量:2
  • 4陈友岱.胆盐诱发急性胰腺炎时胰腺微循环障碍及机理探讨[D].成都:四川大学.2007. 被引量:1
  • 5毛恩强,汤耀卿,李磊,秦帅,武钧,刘伟,雷若庆,张圣道.重症胰腺炎急性反应期控制性液体复苏策略[J].中华外科杂志,2007,45(19):1331-1334. 被引量:33
  • 6SCHORTGEN F, DEYE N, BROCHARD L, et al. Preferred plasma volume expanders for critically ill patients: results of an international survey[J]. Intensive Care Med, 2004,30(12) : 2222-2229. 被引量:1
  • 7BOLDT J, HEESEN M, MULLER M, et al. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients[J]. Anesth Analg, 1996,83: 254-261. 被引量:1
  • 8MARTIN G S, MOSS M, WHEELER A P, et al. A randomized, controlled trial of furosemide with or without alburain in hypoproteinemic patients with acute lung iniury[J]. Crit Care Med, 2005,33(8): 1681-1687. 被引量:1
  • 9黄开红,林萍,聂胜利,刘建化,王凌云,陈其奎,朱兆华.广东地区1316例急性胰腺炎的临床流行病学特征[J].中华内科杂志,2007,46(10):831-834. 被引量:32
  • 10MOFIDI R, MADHAVAN K K, GARDEN O J, et al. An audit of the management of patients with acute pancreatitis against national standards of practice[J]. Br J Surg, 2007,94 (7) : 844-848. 被引量:1

二级参考文献11

  • 1Ai-Jun Zhu,Jing-Sen Shi,Xue-Jun Sun the Laboratory, of Hepatobiliary Surgery, First Hospital of Xi’an Jiaotong University, Xi’an 710061, China.Risk factors influencing mortality of patients with severe acute pancreatitis within 24 hours after admission[J].Hepatobiliary & Pancreatic Diseases International,2003,2(3):453-457. 被引量:6
  • 2黄鹤,贾柳萍,谢春生,古雨平,王海霞.广东南海地区急性胰腺炎的病因分析[J].中国中西医结合消化杂志,2005,13(1):43-44. 被引量:8
  • 3SwaroopVS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA, 2004,291: 2865-2868. 被引量:1
  • 4Mayumi T, Ura H, Arata S, et al. Evidence-based clinical practice guidelines for acute pancreatitis : proposals. J Hepatobiliary Pancreat Surg, 2002, 9:413-422. 被引量:1
  • 5Lankisch PG, Assmus C, Lehnick D, et al. Acute pancreatitis: does gender matter? Dig Dis Sci, 2001 ,46:2470-2474. 被引量:1
  • 6Apte MV, Wilson JS. Alcohol-induced pancreatic injury. Best Pract Res Clin Gastroenterol, 2003,17:593-612. 被引量:1
  • 7De Sanctis JT, Lee M J, Gazelle GS, et al. Prognostic indicators in acute pancreatitis: CT vs. APACHE- Ⅱ. Clin Radiol, 1997,52 : 842-848. 被引量:1
  • 8Appelros S, Borgstrom A. Incidence, aetiology and mortality rate of acute pancreatitis over 10 years in a defined urban population in Sweden. Br J Surg, 1999,86:465-470. 被引量:1
  • 9Isenmann R, Runzi M, Kron M, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology, 2004, 126:997-1004. 被引量:1
  • 10Folsch UR, Nitsche R, Ludtke R, et al. Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis. N Engl J Med, 1997,336:237-242. 被引量:1

共引文献60

同被引文献12

  • 1马瑞申,陈洁.PVC输血袋增塑剂的“耐萃取性”测定[J].生物医学工程学杂志,1993,10(1):98-99. 被引量:1
  • 2QUINTINI G, BARBERA V, IANNITTO E, et al. Contin- uous intravenous infusion of dipyridamoie as adjunctive thera- py in the treatment of thrombotic thrombocytopenic purpura [J]. TransfusApherSci, 2003, 29(2): 141-145. 被引量:1
  • 3DITTRICH S, GERMANAKIS J, DAHNERT I, et al. Ran- domised trial on the influenceof continuous magnesium infu- sionon arrhythmias following cardiopulmonarybypass surgery for congenital heart disease[J]. Intensive Care Med, 2003, 29(7): 1141-1144. 被引量:1
  • 4THABET F, BOURGEOIS J, GUY B, et a]. Continuous in- sulin infusion in hyperglyeaemic very-low-birth-weight infants receiving parenteral nutrition [J]. Clin Nutr, 2003, 22 (6) : 545-547. 被引量:1
  • 5GIULIANI J. A severe delayed infusion reaction induced by trastuzumab: a life-threatening condition[J]. Med Oneol, 2012, 29(5) : 3597-3598. 被引量:1
  • 6THIESEN J, KRDMER I. Physico-chemical stability of do- cetaxel premix solution and docetaxelinfusion solutions in PVC bags and polyolefine containers [J]. Pharm World Sci, 1999, 21(3): 137-141. 被引量:1
  • 7CAI Qiang, BARRIE M, OI.EJEME H, et al. A pilot study of efficacy and safety of continuous intravenousinfusion of pantoprazole in the treatment of severe erosiveesophagitis [J]. Dig Dis Sci, 2008, 53(6): 1500-1505. 被引量:1
  • 8CHANG J Y, XIAO N J, ZHU Min, et al. Leachables from saline-containing IV Bags can alter therapeutic protein proper- ties[J]. PharmRes, 2010, 27(11): 2402-2413. 被引量:1
  • 9HOLMES C J, AIA.WOOD M C. The assessment of air-inlet filters for intravenous infusions in glass bottles [J]. lnt J Pharm, 1978, 1(3): 133-139. 被引量:1
  • 10VAN DOOREN A A. PVC as pharmaceutical packaging ma- terial [J]. Pharmaceutisch Weekblad, 1991, 13(3):109- 118. 被引量:1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部